Description

LuciTram 2mg Tablet (Trametinib) – Uses, Side Effects, Dosage & Price in Pakistan

LuciTram 2mg Tablet (Trametinib) is a prescription targeted cancer medicine used for certain cancers with specific BRAF mutations. It contains Trametinib, a kinase inhibitor that blocks abnormal signaling pathways involved in cancer-cell growth.

Trametinib may be used alone for certain BRAF V600E or V600K mutation-positive melanoma, while it is also used with dabrafenib for several approved cancer indications. The treatment depends on the cancer type, mutation status, previous treatment, and the patient’s overall condition.

LuciTram 2mg Tablet (Trametinib) Uses

LuciTram 2mg may be prescribed for specific cancers when the required BRAF mutation is present.

According to current FDA labeling, trametinib is indicated alone for certain adults with unresectable or metastatic melanoma with BRAF V600E or V600K mutations who have not previously received a BRAF inhibitor.

In combination with dabrafenib, trametinib may be used for:

• Certain unresectable or metastatic melanoma with BRAF V600E or V600K mutations
• Certain melanoma patients after complete surgical removal when lymph nodes are involved
• Metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation
• Locally advanced or metastatic anaplastic thyroid cancer with a BRAF V600E mutation when there are no satisfactory local treatment options
• Certain BRAF V600E mutation-positive solid tumors after previous treatment when there are no satisfactory alternative options
• Certain pediatric patients with BRAF V600E mutation-positive low-grade glioma who require systemic treatment

Because these uses depend on specific genetic mutations, appropriate testing may be required before treatment.

How Trametinib Works

Trametinib is a MEK inhibitor and belongs to the kinase inhibitor class.

Some cancer cells contain abnormal signaling pathways that encourage them to grow and multiply. Trametinib blocks MEK1 and MEK2 signaling within the MAPK pathway, helping reduce signals that promote cancer-cell growth.

When used with dabrafenib, trametinib targets a different part of the same signaling pathway. This combination can be used for cancers with certain BRAF mutations.

LuciTram 2mg Dosage (Trametinib)

The recommended adult dose of trametinib is generally 2mg once daily for approved adult indications. Pediatric dosing may be based on body weight.

LuciTram 2mg should only be taken according to the treatment plan provided by the oncologist. The doctor may adjust or interrupt treatment depending on side effects, medical condition, and treatment response.

Trametinib should be taken at least 1 hour before or 2 hours after a meal. Do not change the prescribed dose or schedule without consulting your healthcare professional.

How to Take LuciTram 2mg

Take LuciTram exactly as prescribed.

• Take it once daily when prescribed on a daily schedule.
• Take it on an empty stomach.
• Take it at least 1 hour before or 2 hours after food.
• Swallow the tablet whole.
• Do not crush or break the tablet unless your healthcare professional specifically provides different instructions.
• Try to take it at approximately the same time each day.

If you vomit after taking trametinib, do not automatically take another dose. Follow your doctor’s instructions and continue with your prescribed schedule.

LuciTram 2mg Side Effects

Trametinib can cause side effects, and not every patient will experience the same reactions.

Common side effects can include:

• Skin rash
• Diarrhea
• Tiredness
• Swelling or lymphedema
• Nausea
• Vomiting
• Headache
• Muscle or joint pain
• Reduced appetite
• Fever, particularly when used with dabrafenib

The exact side-effect profile can vary depending on whether trametinib is used alone or together with dabrafenib.

Serious problems can also occur, including bleeding, blood clots, heart problems, serious eye problems, lung inflammation, severe skin reactions, and gastrointestinal complications.

Contact your healthcare professional promptly if you experience severe or unusual symptoms.

Important Precautions

Before starting LuciTram, tell your doctor if you have a history of:

• Heart problems
• High blood pressure
• Eye or vision problems
• Lung disease
• Bleeding or blood-clotting problems
• Diabetes or high blood sugar
• Liver problems
• Previous severe skin reactions

Trametinib can affect heart function. The FDA label recommends assessment of left ventricular ejection fraction before treatment, after about one month, and periodically during treatment.

Trametinib can also cause serious eye problems. Report new or worsening vision changes to your healthcare professional promptly.

Tell your doctor about planned surgery or other major medical procedures. Your treatment may need to be managed around certain procedures.

Trametinib can cause fetal harm. Patients who can become pregnant should discuss effective contraception and pregnancy planning with their healthcare professional. Breastfeeding is not recommended during treatment according to current FDA labeling.

LuciTram 2mg Tablet (Trametinib) Drug Interactions

Tell your doctor about all medicines, vitamins, supplements, and herbal products you use before starting trametinib.

When trametinib is used with dabrafenib, medicines that strongly affect certain drug-metabolizing enzymes may require special consideration. Your doctor or pharmacist can review your complete medication list to identify possible interactions.

Do not start or stop another medicine without discussing it with your healthcare professional.

LuciTram 2mg Price in Pakistan

The LuciTram 2mg Tablet price in Pakistan may vary depending on availability, supplier, imported stock, packaging, and market conditions.

Specialized cancer medicines may not have a fixed price across all suppliers. Therefore, patients should confirm the current product details, availability, and price before ordering.

For current information about LuciTram 2mg in Pakistan, you can contact Impo Medic.

How to Buy LuciTram 2mg in Pakistan

If you want to buy LuciTram 2mg in Pakistan, obtain it from a reliable medicine supplier and use it only under the supervision of your oncologist.

Before ordering, confirm:

• Product name and 2mg strength
• Active ingredient: Trametinib
• Manufacturer and packaging information
• Current availability
• Prescription requirements
• Appropriate storage conditions

Impo Medic provides information about specialized and imported medicines for patients in Pakistan. Because trametinib is a prescription cancer medicine, treatment decisions should always be made by a qualified healthcare professional.

Why Choose Impo Medic?

At Impo Medic, our aim is to make information about specialized medicines easier to understand for patients in Pakistan. Our product pages provide practical information about uses, dosage, side effects, precautions, availability, and buying guidance.

For targeted medicines such as LuciTram 2mg Tablet, understanding mutation requirements and safety precautions is particularly important. Impo Medic focuses on clear product information while encouraging patients to follow their oncologist’s treatment plan.

FAQs About LuciTram 2mg Tablet (Trametinib)

What isLuciTram 2mg Tablet (Trametinib) used for?

LuciTram contains trametinib and may be used for certain cancers with specific BRAF mutations, including selected melanoma, lung cancer, thyroid cancer, solid tumors, and pediatric low-grade glioma indications. Some uses require combination treatment with dabrafenib.

What is the active ingredient in LuciTram 2mg?

The active ingredient is Trametinib.

Is LuciTram 2mg a chemotherapy medicine?

Trametinib is a targeted kinase inhibitor, specifically a MEK inhibitor. It works by blocking signaling pathways involved in the growth of certain cancer cells.

How should LuciTram 2mg be taken?

Trametinib is generally taken once daily on an empty stomach, at least 1 hour before or 2 hours after a meal. Follow the exact instructions given by your doctor.

Can LuciTram be used with dabrafenib?

Yes. Trametinib is approved for use with dabrafenib for several cancer indications involving specific BRAF mutations.

Does LuciTram require mutation testing?

For several approved indications, treatment selection depends on identifying a specific BRAF mutation in the tumor. Your doctor will determine which testing is appropriate before treatment.

Where can I check LuciTram 2mg availability in Pakistan?

You can contact Impo Medic to ask about the current availability of LuciTram 2mg Tablet in Pakistan.

Final Thoughts

LuciTram 2mg Tablet (Trametinib) is a targeted prescription cancer medicine used for selected cancers associated with specific BRAF mutations. It may be used alone for certain melanoma patients or together with dabrafenib for several approved indications.

Because trametinib can cause important heart, eye, lung, bleeding, skin, and other complications, treatment should remain under appropriate medical supervision. If you are looking for LuciTram 2mg Tablet in Pakistan, confirm product availability and use the medicine only according to your oncologist’s instructions.